184 related articles for article (PubMed ID: 12113029)
21. Current perspectives in the treatment of metastatic colorectal cancer.
Köhne CH; Folprecht G
Ann Oncol; 2004; 15 Suppl 4():iv43-53. PubMed ID: 15477334
[No Abstract] [Full Text] [Related]
22. Initial therapy with FOLFOXIRI and bevacizumab for metastatic colorectal cancer.
Loupakis F; Cremolini C; Masi G; Lonardi S; Zagonel V; Salvatore L; Cortesi E; Tomasello G; Ronzoni M; Spadi R; Zaniboni A; Tonini G; Buonadonna A; Amoroso D; Chiara S; Carlomagno C; Boni C; Allegrini G; Boni L; Falcone A
N Engl J Med; 2014 Oct; 371(17):1609-18. PubMed ID: 25337750
[TBL] [Abstract][Full Text] [Related]
23. Personalized dosing via pharmacokinetic monitoring of 5-fluorouracil might reduce toxicity in early- or late-stage colorectal cancer patients treated with infusional 5-fluorouracil-based chemotherapy regimens.
Kline CL; Schiccitano A; Zhu J; Beachler C; Sheikh H; Harvey HA; Mackley HB; McKenna K; Staveley-O'Carroll K; Poritz L; Messaris E; Stewart D; Sivik J; El-Deiry WS
Clin Colorectal Cancer; 2014 Jun; 13(2):119-26. PubMed ID: 24461492
[TBL] [Abstract][Full Text] [Related]
24. The role of oxaliplatin in the treatment of advanced metastatic colorectal cancer: prospects and future directions.
Schmoll HJ
Semin Oncol; 2002 Oct; 29(5 Suppl 15):34-9. PubMed ID: 12422306
[TBL] [Abstract][Full Text] [Related]
25. Review article: colorectal cancer chemotherapy.
Gill S; Thomas RR; Goldberg RM
Aliment Pharmacol Ther; 2003 Oct; 18(7):683-92. PubMed ID: 14510741
[TBL] [Abstract][Full Text] [Related]
26. Oxaliplatin: a new agent for colorectal cancer.
Pelley RJ
Curr Oncol Rep; 2001 Mar; 3(2):147-55. PubMed ID: 11177747
[TBL] [Abstract][Full Text] [Related]
27. Irinotecan plus 5-FU and leucovorin in advanced colorectal cancer: North American trials.
Goldberg RM; Erlichman C
Oncology (Williston Park); 1998 Aug; 12(8 Suppl 6):59-63. PubMed ID: 9726093
[TBL] [Abstract][Full Text] [Related]
28. New chemotherapeutic strategies in colorectal cancer.
Moehler M; Teufel A; Galle PR
Recent Results Cancer Res; 2005; 165():250-9. PubMed ID: 15865041
[TBL] [Abstract][Full Text] [Related]
29. Current treatment options for advanced colorectal cancer.
Rougier P; Mitry E
Semin Oncol; 2000 Oct; 27(5 Suppl 10):30-3. PubMed ID: 11049030
[No Abstract] [Full Text] [Related]
30. Weekly oxaliplatin, high-dose folinic acid and 24h-5-fluorouracil (FUFOX) as salvage therapy in metastatic colorectal cancer patients pretreated with irinotecan and folinic acid/5-fluorouracil regimens.
Moehler M; Hoffmann T; Hildner K; Siebler J; Galle PR; Heike M
Z Gastroenterol; 2002 Dec; 40(12):957-64. PubMed ID: 12564419
[TBL] [Abstract][Full Text] [Related]
31. Treatment patterns and metastasectomy among mCRC patients receiving chemotherapy and biologics.
Song X; Zhao Z; Barber B; Gregory C; Wang PF; Long SR
Curr Med Res Opin; 2011 Jan; 27(1):123-30. PubMed ID: 21128878
[TBL] [Abstract][Full Text] [Related]
32. Oxaliplatin, folinic acid and 5-fluorouracil (FOLFOX-4) combination chemotherapy as second-line treatment in advanced colorectal cancer patients with irinotecan failure: a Korean single-center experience.
Park SH; Sung JY; Han SH; Baek JH; Oh JH; Bang SM; Cho EK; Shin DB; Lee JH
Jpn J Clin Oncol; 2005 Sep; 35(9):531-5. PubMed ID: 16027146
[TBL] [Abstract][Full Text] [Related]
33. Irinotecan as first-line treatment of colorectal cancer: new indication. A modest advantage.
Prescrire Int; 2001 Apr; 10(52):41-3. PubMed ID: 11718156
[TBL] [Abstract][Full Text] [Related]
34. The role of irinotecan and oxaliplatin in the treatment of advanced colorectal cancer.
Khayat D; Gil-Delgado M; Antoine EC; Nizri D; Bastian G
Oncology (Williston Park); 2001 Apr; 15(4):415-29; discussion 429-30, 433-4. PubMed ID: 11346931
[TBL] [Abstract][Full Text] [Related]
35. Intensive systemic chemotherapy combined with surgery for metastatic colorectal cancer: results of a phase II study.
Taïeb J; Artru P; Paye F; Louvet C; Perez N; André T; Gayet B; Hebbar M; Goebel FM; Tournigand C; Parc R; de Gramont A
J Clin Oncol; 2005 Jan; 23(3):502-9. PubMed ID: 15659495
[TBL] [Abstract][Full Text] [Related]
36. What's new in ... colorectal cancer. Meaningful progress in therapy options.
Polansky M; Ross AC
JAAPA; 2009 Apr; 22(4):51-2. PubMed ID: 19452823
[No Abstract] [Full Text] [Related]
37. Meta-analysis of new treatment strategies for metastatic colorectal cancer.
Parvez T; Mahrous AR; Fawazi A
J Coll Physicians Surg Pak; 2004 Oct; 14(10):638-42. PubMed ID: 15456561
[TBL] [Abstract][Full Text] [Related]
38. Evidence-based update of chemotherapy options for metastatic colorectal cancer.
Damjanovic D; Thompson P; Findlay MP
ANZ J Surg; 2004 Sep; 74(9):781-7. PubMed ID: 15379811
[TBL] [Abstract][Full Text] [Related]
39. [Chemotherapy of patients with colorectal carcinoma].
Punt CJ
Ned Tijdschr Geneeskd; 2005 Jun; 149(26):1441-7. PubMed ID: 16010954
[TBL] [Abstract][Full Text] [Related]
40. [A review of FOLFOXIRI chemotherapy for the 1st line treatment of metastatic colorectal cancer].
Kawakami H; Satoh T; Nakagawa K
Nihon Rinsho; 2011 Apr; 69 Suppl 3():439-45. PubMed ID: 22214001
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
